Sangamo Therapeutics
About Sangamo Therapeutics
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Underwritten Offering T: - FT: Underwritten Offering |
A: 25000000 MR: - FA: 25.0 Million FAN: 25000000 |
D: 2026-02-03 FD: 2026-02-03 |
2 investors |
| 2 |
RT: Underwritten Offering T: - FT: Underwritten Offering |
A: 23000000 MR: - FA: approximately $23.0 million FAN: 23000000 |
D: 2025-05-12 FD: 2025-05-12 |
1 investors |
| 3 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 24000000 MR: - FA: 24.0 million FAN: 24000000 |
D: 2024-03-22 FD: 2024-03-22 |
2 investors |
Growth Metrics
Team & Leadership
Bryan
Music Teacher
Lori
Hospital Lab Technician
Matt
Fabry Disease Patient
Elizabeth
Fabry Disease
Israel
Hemophilia A
Miles
Water Polo Athlete
Recent News
Sangamo Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- sangamo.com
- Industries
- Biotechnology / Genomic Medicine
- Company Size
- ~520 employees (est.)
- Locations
-
not specified
New Orleans, LA
San Diego, CA
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro